Loading, please wait....jpg)
.jpg)
The Premier December 11, 2024 Antimicrobial Stewardship Forum will feature a continuing education (CE) activity from 12:00 - 1:00 PM EST. We are pleased to provide application-based, ACPE-accredited CE credit to pharmacists and pharmacy technicians during our webinar meetings.
Understanding and Managing C. difficile Infection: Pathogenesis, Treatment and Recurrence Prevention
SPEAKER: Emily Drwiega, PharmD, BCIDP, BCPS, AAHIVP, Visiting Clinical Assistant Professor of Pharmacy Practice, Clinical Pharmacist, Department of Pharmacy Practice, University of Illinois at Chicago, College of Pharmacy, Chicago, IL
ACPE Universal Activity Number 0122-0000-24-044-L01-P [0.1 CEU] [1.0 Contact Hr] (Application-based CE)
Date: Dec 11, 2024 12:00 PM - 01:00 PM
Fee
$0.00
CE Hours
1.00
CE Units
0.100
Registration closes on Dec 11, 2024 12:10 PM
Activity Type
- Application
Target Audience(s)
- Pharmacists
Accreditation(s)
|
Premier, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
|
Requirements for CE Credit
CE participation will be provided to CPE Monitor within 45 days of the CE activity upon CE registration, confirmation of participation for the entire activity, and completion of online learning assessment questions and speaker evaluation administered post-session.
Objectives
- Describe the pathogenesis of Clostridioides difficile infection and recurrence
- Given a case study, select an appropriate medication (drug, dose, duration, etc.) for the treatment of Clostridioides difficile infection
- Compare options for the prevention of recurrent Clostridioides difficile infection
Speaker(s)/Author(s)
|
Emily Drwiega, PharmD, BCIDP, BCPS, AAHIVP
|
Activity Number
0122-0000-24-044-L01-P
Date:
12/11/24
Time:
12:00 PM - 01:00 PM
CE Hours
1.00